Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
Clinical trial NCT04863014 · TERMINATED
Trial details
- NCT number
- NCT04863014
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2023-02-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.